ACLEXA
General data
Product class:
Authorized package
Medicinal product class:
For human use
Package code:
1596719
Name of medicinal product:
ACLEXA
Active substances:
Celecoxib
Estonian
,
English
,
Latin
ATC code:
M01AH01
Dosage form:
capsule, hard
Route of administration:
oral use
Strengh:
100mg
Amount in package:
30TK
Legal status for supply*:
Subject to medicinal prescription
Class of active substance:
Additional information:
Indication:
is indicated in adults for the symptomatic relief in the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. The decision to prescribe a selective cyclooxygenase-2 (COX-2) inhibitor should be based on an assessment of the individual patient's overall risks (see sections 4.3 and 4.4).
Safety features:
Yes
Summary of product characteristics (SPC):
(last updated 13 October 2021)
Package information leaflet (PIL):
EST
(last updated 13 August 2020)
Labelling:
(last updated 13 August 2020)
Last imported to Estonia:
27 November 2023
Marketing authorization
Marketing authorization holder:
KRKA d.d. Novo mesto
Marketing authorization number:
832713
Marketing authorization issued on:
20 December 2013
Marketing authorization expires on:
Unlimited
Marketing authorization procedure type:
Decentralised
Reimbursements
Percent
Valid from
Valid until
Valid
Diagnosis
Doctor's speciality
Primary
Age
Other
50
24/10/2023
Yes
No
100
24/10/2023
Yes
No
until 4 years
Prices
Reference price:
6.60 EUR
Under reference price:
No
Reference price of daily dose:
0.44 EUR
Perscription conditions and restrictions
Description
Additional condition
Hambaarstil on õigus välja kirjutada
Entry/Changing date: 13 October 2021
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription